while the Danish plant in Måløv will be used for 'tableting and packaging of oral semaglutide and future oral products'. Both are due to come online in 2020, with the US facility employing 700 ...

The proprietary Self-Emulsifying Drug Delivery System (SEDDS) formulation in form of orally dispersible films allows absorption of sublingually administrated peptides such as GLP-1 (Semaglutide ...